Phase II results presented for ustekinumab in patients with active systemic lupus erythematosus Oct. 5, 2018
China Pharmaceutical University, Hefei Yigong Medicine describe new colchicine derivatives Sep. 20, 2018
Results of a first-in-human study of the JAK 1 inhibitor PF-04965842 in healthy subjects Sep. 13, 2018
RSS